ESR1 and neoplasm: Given that the intrinsic levels of estradiol are highly variable between different breast tumors [15,16] and that HOXB13 may be a coactivating factor in ER signaling [17], one may speculate that high HOXB13 protein levels can contribute to increased ER activity despite a low estradiol concentration within the tumor.